^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AUR-107

    i
    Other names: AUR-107, AUR107, AUR 107
    Associations

    News

    Trials
    Company:
    Dr. Reddy’s
    Drug class:
    CBP inhibitor, EP300 inhibitor
    Related drugs:
    Associations

    News

    Trials
    11ms
    A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) (clinicaltrials.gov)
    P1, N=50, Recruiting, Aurigene Discovery Technologies Limited | Not yet recruiting --> Recruiting
    Enrollment open
    |
    MUC16 (Mucin 16, Cell Surface Associated)
    |
    AUR-107
    over1year
    A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) (clinicaltrials.gov)
    P1, N=50, Not yet recruiting, Aurigene Discovery Technologies Limited
    New P1 trial • Metastases
    |
    AUR-107